Adult Soft Tissue Sarcoma

Oncology
3
Pipeline Programs
2
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
1
1
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Nanobiotix
NanobiotixPARIS, France
2 programs
1
1
NBTXR3Phase 2/31 trial
NBTXR3Phase 11 trial
Active Trials
NCT01433068CompletedEst. Feb 2015
NCT02379845CompletedEst. Sep 2020
Boehringer Ingelheim
Boehringer IngelheimINGELHEIM, Germany
1 program
1
Ezabenlimab + BI907828Phase 21 trial
Active Trials
NCT06084689Withdrawn0Est. Jul 2024

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
NanobiotixNBTXR3
Boehringer IngelheimEzabenlimab + BI907828
NanobiotixNBTXR3

Clinical Trials (3)

NBTXR3 Crystalline Nanoparticles and Radiation Therapy in Treating Randomized Patients in Two Arms With Soft Tissue Sarcoma of the Extremity and Trunk Wall

Start: Mar 2015Est. completion: Sep 2020
Phase 2/3Completed
NCT06084689Boehringer IngelheimEzabenlimab + BI907828

Targeting MDMD and PD1 in Tumors With Tertiary Lymphoid Structures

Start: Jun 2024Est. completion: Jul 20240
Phase 2Withdrawn

NBTXR3 Crystalline Nanoparticles and Radiation Therapy in Treating Patients With Soft Tissue Sarcoma of the Extremity

Start: Oct 2011Est. completion: Feb 2015
Phase 1Completed

Related Jobs in Oncology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space